Re: Can Aydogdu, Benso John, Clara Seizer, et al. Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy. Eur Urol Open Sci 2026;92:10–8.
Re: Can Aydogdu, Benso John, Clara Seizer, et al. Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy. Eur Urol Open Sci 2026;92:10–8. // European Urology Open Science. – URL: https://www.sciencedirect.com/science/article/pii/S2666168326033537?dgcid=rss_sd_all
Re: Can Aydogdu, Benso John, Clara Seizer, et al. Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy. Eur Urol Open Sci 2026;92:10–8. European Urology Open Science. https://www.sciencedirect.com/science/article/pii/S2666168326033537?dgcid=rss_sd_all
“Re: Can Aydogdu, Benso John, Clara Seizer, et al. Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy. Eur Urol Open Sci 2026;92:10–8.” European Urology Open Science.
@article{article45485,
title = {Re: Can Aydogdu, Benso John, Clara Seizer, et al. Oncologic Outcomes in a Contemporary “PROTEUS-like” Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy. Eur Urol Open Sci 2026;92:10–8.},
journal = {European Urology Open Science},
url = {https://www.sciencedirect.com/science/article/pii/S2666168326033537?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...